Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph C Presti

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
European Urology|April 17, 2013
Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomySanoj Punnen, Stephen J Freedland, Joseph C Presti, et al.
BJU International|May 27, 2009
Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH databaseDaniel M Moreira, Jayakrishnan Jayachandran, Joseph C Presti, et al.
BJU International|September 24, 2010
A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) databaseHoward S Kim, Daniel M Moreira, Matthew R Smith, et al.
Urology|June 19, 2007
Do racial differences in prostate size explain higher serum prostate-specific antigen concentrations among black men?John C Mavropoulos, Alan W Partin, Christopher L Amling, et al.
Cancer|June 30, 2010
Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) DatabaseRobert J Hamilton, Lionel L Banez, William J Aronson, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 1, 2010
Postoperative prostate-specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databasesDaniel M Moreira, Joseph C Presti, William J Aronson, et al.
The American Journal of Surgical Pathology|April 27, 2007
Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarrayJohn P T Higgins, Gulsah Kaygusuz, Lingli Wang, et al.
The Journal of Urology|April 14, 2012
Are repeat prostate biopsies safe? A cohort analysis from the SEARCH databaseRyan P Kopp, Sean P Stroup, Florian R Schroeck, et al.
BJU International|November 17, 2009
Re-calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomyFlorian R Schroeck, Michael W Kattan, Judd W Moul, et al.
European Urology Focus|July 30, 2017
The Stockholm-3 (STHLM3) Model can Improve Prostate Cancer Diagnostics in Men Aged 50-69 yr Compared with Current Prostate Cancer TestingMartin Eklund, Tobias Nordström, Markus Aly, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
European Urology|April 17, 2013
Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomySanoj Punnen, Stephen J Freedland, Joseph C Presti, et al.
BJU International|May 27, 2009
Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH databaseDaniel M Moreira, Jayakrishnan Jayachandran, Joseph C Presti, et al.
BJU International|September 24, 2010
A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) databaseHoward S Kim, Daniel M Moreira, Matthew R Smith, et al.
Urology|June 19, 2007
Do racial differences in prostate size explain higher serum prostate-specific antigen concentrations among black men?John C Mavropoulos, Alan W Partin, Christopher L Amling, et al.
Cancer|June 30, 2010
Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) DatabaseRobert J Hamilton, Lionel L Banez, William J Aronson, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 1, 2010
Postoperative prostate-specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databasesDaniel M Moreira, Joseph C Presti, William J Aronson, et al.
The American Journal of Surgical Pathology|April 27, 2007
Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarrayJohn P T Higgins, Gulsah Kaygusuz, Lingli Wang, et al.
The Journal of Urology|April 14, 2012
Are repeat prostate biopsies safe? A cohort analysis from the SEARCH databaseRyan P Kopp, Sean P Stroup, Florian R Schroeck, et al.
BJU International|November 17, 2009
Re-calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomyFlorian R Schroeck, Michael W Kattan, Judd W Moul, et al.
European Urology Focus|July 30, 2017
The Stockholm-3 (STHLM3) Model can Improve Prostate Cancer Diagnostics in Men Aged 50-69 yr Compared with Current Prostate Cancer TestingMartin Eklund, Tobias Nordström, Markus Aly, et al.
Pageof 12